Business

With proper precautions, the risk of a day at work, a ride on the bus, or a workout at the gym may be acceptable — but those risks compound day after day.

The drug buprenorphine is a safer and more effective treatment for opioid use disorder than its predecessors. But one study says not enough people are using it.

SOM alum Matt Walton, whose emergency management software was used to direct responses to past pandemics, examines the cost of lessons not learned.

Yale’s Jennifer Richeson and Michael Kraus discuss their research on the racial wealth gap, and why Americans believe it is much smaller than it really is.

For the third consecutive year, Yale took home the trophy, as Pradyut Paul (SOM ’21) of Bild was named the winner.

Dayo Olopade ’15 M.B.A., a lead for film and television partnerships at Google, discusses the global disruption of production and consumption of media.

A new study by SOM’s James Choi revisits landmark research about how mutual funds behave, and finds that conventional wisdom doesn’t describe modern markets.

In a recent panel, Yale SOM’s Teresa Chahine discussed how businesses and investors can empower local Black-owned businesses and increase opportunity.

For dozens of Yale SOM students, the COVID-19 global pandemic served as a call to embody the school’s mission to educate leaders for business and society.

Yale SOM’s Edward Kaplan, an operations and modeling expert, discusses what Connecticut has gotten right in tackling the pandemic — and what risks still remain.